May 23 witnessed the successful conclusion of the 17th West-East Small Animal Veterinary Congress (WESAVC 2025) in Xiamen. As one of the most influential pet medical industry galas in the Asia-Pacific region, this congress gathered top global veterinarians, experts, scholars, and industry leaders to explore cutting-edge technologies and development trends in pet healthcare.
During the exhibition, Neovet Dx debuted with a diverse product matrix, covering Al Multifunctional Morphological Analyzer, Dry Chemistry Analyzer, Quantitative Real-time PCR Analyzer, Immunofluorescence Analyzer, Capture Chromatography Assay and Indirect Chromatography Assay, etc., attracting numerous veterinarians and creating a bustling atmosphere in the on-site interactive experience zone.
· Neopod-A1 VET enables intelligent detection and analysis of formed elements in clinical samples (such as blood, urine, feces, etc.), playing a crucial role in disease diagnosis, treatment, and monitoring.
· Neopod-C1 VET adopts a unique multi-layer membrane coating process to effectively handle the impact of abnormal samples (lipemia, hemolysis, icterus) on biochemical results, ensuring accuracy. With simple operation, it provides efficient biochemical test panels that can be flexibly combined for clinical detection.
· Neopod-M4 VET is suitable for early screening and diagnosis of various pathogen infections, enabling rapid and accurate disease diagnosis. It delivers precise results within 40 minutes, seizing the best treatment time for pets.
· Neopod-F1 VET supports clinical rapid testing in multiple scenarios. Using self-developed raw materials, it enables multi-sample type detection, anti-interference multi-marker joint testing, and innovative signal integration, providing more precise assistance for pet clinical diagnosis.
· The Neovet Dx canine/feline-specific blood typing card, based on exclusive patented solid-phase chromatography 2.0 technology and verified by 300,000 clinical cases, allows rapid blood type determination with "1 drop of blood in 1 minute". Requiring no equipment and featuring ultra-simple operation, it applies to multiple scenarios such as transfusion, physical examination, and breeding screening.
· Additionally, Neovet Dx has developed canine/feline-specific crossmatching products. With extremely simplified operation, it provides results for major crossmatch, minor crossmatch, and autoagglutination tests within 10 minutes, eliminating the traditional complex procedures for veterinarians and aiding more pet rescues.
Neovet Dx is dedicated to providing more high-quality products for the pet medical industry. While enhancing accuracy, we save costs in time, space, and manpower for clinical pet testing, making clinical detection of pet diseases simpler, more efficient, and more precise. In the future, we will continue to join hands with veterinarians worldwide to safeguard pet health!
